Drug Type Small molecule drug |
Synonyms PH009 1, PH0091 |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors), EGFR T790M inhibitors(EGFR T790M inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR-mutated non-small Cell Lung Cancer | IND Approval | CN | 19 Jun 2024 | |
EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma | Preclinical | CN | 17 Apr 2023 |